Market Whales and Their Recent Bets on Edwards Lifesciences Options
Portfolio Pulse from Benzinga Insights
Deep-pocketed investors are showing a bullish trend towards Edwards Lifesciences (NYSE:EW) options, with significant options activity detected by Benzinga. The majority of these investors are bullish, targeting a price range of $50.0 to $72.5. Recent analyst ratings are mixed, with some downgrades and a few maintaining an outperform rating.
July 26, 2024 | 5:01 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Edwards Lifesciences (NYSE:EW) has seen significant options activity, with 64% of investors leaning bullish. The stock is currently up 4.18%, and analysts have mixed ratings with an average target price of $76.4.
The significant options activity, predominantly bullish, suggests strong investor interest and potential upward movement in the short term. The mixed analyst ratings provide a balanced view, but the overall sentiment leans positive.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100